Effects of Replacing Lantus With Basalin on the Glycemic Variation in Patients
Phase of Trial: Phase IV
Latest Information Update: 12 Jun 2019
Price : $35 *
At a glance
- Drugs Insulin glargine (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 09 Jun 2019 Planned End Date changed from 30 Jan 2019 to 30 Jul 2019.
- 09 Jun 2019 Status changed from not yet recruiting to recruiting.
- 23 Aug 2018 New trial record